Veeda Clinica Research
-3.03 %As of May 11, 2025, Veeda Clinica Research share price is INR 480.00 per share and the face value is INR 2.00 per share. The lot size of Veeda Clinica Research is 0 shares. The 52 week high for Veeda Clinica Research is INR 575.00, while the 52 week low is INR 480.00
About Veeda Clinica Research
A Comprehensive Overview of Price & Journey
Understanding Veeda Clinica Research Inception and Growth
SHOW MORE...Fundamentals
Market Cap (in cr.)
₹ 30239926080
P/E Ratio
1.57
P/B Ratio
2.85
Debt to Equity
0.00
ROE (%)
58.65
Book Value
168.67
Face Value
2.00
Total Shares
62999846
Category
Unlisted Shares
Unlisted CMP
₹ 0 /
Share
Lot Size
0 Shares
52 Week High
₹575.00
52 Week Low
₹480.00
Depository
NSDL & CDSL
PAN Number
AACCC3633Q
ISIN Number
INE01HQ01026
CIN
U73100GJ2004PLC044023
Sector
Health Care
Financials
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | - | - | 223.93 | 296.15 |
| Other Income | - | - | 4.23 | 9.15 |
| COGS | - | - | 18.83 | 17.81 |
| Gross Profit | - | - | 209.33 | 287.49 |
| Total Expense | - | - | 164.02 | 223.93 |
| EBIDTA | - | - | 45.31 | 63.56 |
| D&A | - | - | 15.53 | 21.13 |
| EBIT | - | - | 29.78 | 42.43 |
| Interest Expense | - | - | 4.58 | 5.33 |
| PBT | - | - | 25.20 | 37.10 |
| TAX | - | - | 6.87 | 11.15 |
| PAT | - | - | 18.33 | 25.95 |
| Diluted EPS | - | - | 3.90 | 4.90 |
| Basic EPS | - | - | 3.91 | 4.91 |
| Total income | 0.00 | 0.00 | 228.16 | 305.30 |
ASSETS
| CURRENT ASSETS | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Cash and Cash Equivalents | - | - | 57.72 | 33.32 |
| Trade Payables | - | - | 77.39 | 71.14 |
| Inventory | - | - | 6.99 | 4.90 |
| Other Current Assets | - | - | 163.03 | 153.47 |
| Total Current Assets | 0.00 | 0.00 | 305.13 | 262.83 |
| NON CURRENT ASSETS | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Plant Property and Equipment | - | - | 77.71 | 107.17 |
| Long Term Investment | - | - | 165.13 | 213.15 |
| Other Non Current Assets | - | - | 48.67 | 77.34 |
| TOTOAL NON CURRENT ASSSETS | 0.00 | 0.00 | 291.51 | 397.66 |
| Total Assets | 0.00 | 0.00 | 596.64 | 660.49 |
|---|
| CURRENT LIABILITES | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| TRADW Payable | - | - | 21.48 | 19.19 |
| Other Current Liab | - | - | 67.20 | 77.21 |
| Total Current Liab | 0.00 | 0.00 | 88.68 | 96.40 |
| NON CURRENTLIABILITIES | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Long Term Debt | - | - | - | - |
| Deffered Tax Liab | - | - | - | - |
| Other Non Current Liab | - | - | 34.24 | 42.88 |
LIABILITIES
| EQUITY | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | - | - | 10.57 | 10.58 |
| Reserves And Surplus | - | - | - | - |
| Other Equity | - | - | 463.18 | 510.60 |
| Retained Earnings | - | - | - | - |
| share Equity | 0.00 | 0.00 | 473.75 | 521.18 |
| Total Liabilities | 0.00 | 0.00 | 507.99 | 564.06 |
|---|
| CASH FLOW STAT | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Cash Flow from operating | - | - | 12.73 | 75.06 |
| Cash Flow from financing | - | - | 172.10 | 8.15 |
| Cash Flow from investing | - | - | -141.83 | -106.71 |
| Net cash flow | 0.00 | 0.00 | 43.00 | -23.50 |
Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Frequently Asked Questions
3. What is the lock-in period of Veeda Clinica Research/Pre-IPO shares after the shares gets listed?
The lockin period is of 6 months for pre-ipo investors i.e. they cannot sell their shares for 6 months after they get listed. However, they can definitely sell the shares in pre-ipo market before they get listed.
4. What is the average ticket size for investing in unlisted shares?
5. How to check credit of Veeda Clinica Research/Pre-IPO shares?
6. How is valuation of Veeda Clinica Research/Pre-IPO shares is decided?
9. Difference Between Unlisted Company & Listed Company?
10. Short-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
11. Long-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
12. Applicability of Taxes on Unlisted Shares/Pre-IPO shares once it is listed?
13. IS PRE IPO market same as grey market?
14. Who sells private shares?
15. Investing in Veeda Clinica Research legal in India?